CNSP Research and Charts

CNSP - CNS Pharmaceuticals Inc Ordinary Shares (Healthcare: Biotechnology)

Projected Earnings Date: 2024-08-16 (Delayed quote data 2025-01-06)

Last 0.12	Change ⇓ 0.00 (0.00%)	Volume 243,703,564
	Open 0.15	High 0.16	Low 0.11

8EMA (Daily) 0.12	40EMA (Daily) 0.13	50EMA (Daily) 0.17	STO (Daily) 53.333	MACD Hist (Daily) 0.007
8EMA (Weekly) 0.121	40EMA (Weekly) 10.34	50EMA (Weekly) 20.64	STO (Weekly) 4.444	MACD Hist (Weekly) 2.563


Company Profile
CNS Pharmaceuticals Inc is a preclinical stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.